Published in Int J Dermatol on May 01, 2006
Recent advances in the prevention and treatment of skin cancer using photodynamic therapy. Expert Rev Anticancer Ther (2010) 1.21
Large superficial Basal cell carcinoma arising in the scalp. Ann Dermatol (2011) 1.11
Management of superficial basal cell carcinoma: focus on imiquimod. Clin Cosmet Investig Dermatol (2009) 1.08
Advances in the use of topical imiquimod to treat dermatologic disorders. Ther Clin Risk Manag (2008) 1.01
Basal cell carcinoma of the head and neck. J Skin Cancer (2010) 0.98
Focus on Basal cell carcinoma. J Skin Cancer (2010) 0.96
A case of superficial giant Basal cell carcinoma with satellite lesions on scalp. Ann Dermatol (2011) 0.89
Basal Cell Carcinoma on the Pubic Area: Report of a Case and Review of 19 Korean Cases of BCC from Non-sun-exposed Areas. Ann Dermatol (2011) 0.88
Nonsurgical treatment options for Basal cell carcinoma. J Skin Cancer (2011) 0.87
Basal cell carcinoma: 10 years of experience. J Skin Cancer (2010) 0.86
Pre-treatment deep curettage can significantly reduce tumour thickness in thick Basal cell carcinoma while maintaining a favourable cosmetic outcome when used in combination with topical photodynamic therapy. J Skin Cancer (2011) 0.86
Advances in the management of basal cell carcinoma. F1000Prime Rep (2015) 0.85
Presence of interferon regulatory factor-1 in aggressive and nonaggressive histological variants of Basal cell carcinoma specimens. J Cutan Aesthet Surg (2010) 0.82
Extensive basal cell carcinoma of the forehead and anterior scalp: use of helical tomotherapy as a radiotherapy treatment modality. Br J Radiol (2010) 0.82
Patched knockout mouse models of Basal cell carcinoma. J Skin Cancer (2012) 0.82
Adjuvant approaches to enhance cryosurgery. J Biomech Eng (2009) 0.82
Novel investigational drugs for basal cell carcinoma. Expert Opin Investig Drugs (2010) 0.78
Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat Rev Clin Oncol (2017) 0.78
A Case of Axillary Adenoid Basal Cell Carcinoma. Ann Dermatol (2008) 0.75
Possibility for the Conjugated Use of Photodynamic Therapy and Electrosurgical Devices. PLoS One (2015) 0.75
The importance of superficial basal cell carcinoma in a retrospective study of 139 patients who underwent Mohs micrographic surgery in a Brazilian university hospital. Clinics (Sao Paulo) (2015) 0.75
Direct long bone invasion by Basal cell carcinoma: a case report and review of the literature. Eplasty (2013) 0.75
Traditional versus streamlined management of basal cell carcinoma (BCC): A cost analysis. J Am Acad Dermatol (2015) 0.75
The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol (2011) 1.40
Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis (2010) 1.22
Dermatofibrosarcoma protuberans: a case report and review of the literature. J Clin Aesthet Dermatol (2008) 1.16
Atypical mycobacterial cutaneous infections. Dermatol Clin (2009) 1.15
Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol (2013) 1.08
Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol (2011) 1.07
Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis (2007) 1.03
Anti-TNF agents for the treatment of psoriasis. J Drugs Dermatol (2009) 0.98
Anti-inflammatory activity of tetracyclines. Dermatol Clin (2007) 0.98
Pathways to managing atopic dermatitis: consensus from the experts. J Clin Aesthet Dermatol (2013) 0.98
Calciphylaxis: a review. J Clin Aesthet Dermatol (2008) 0.98
Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol (2010) 0.92
Demodex dermatitis: a retrospective analysis of clinical diagnosis and successful treatment with topical crotamiton. J Clin Aesthet Dermatol (2009) 0.92
Pathogenesis of acne vulgaris: recent advances. J Drugs Dermatol (2009) 0.92
Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience. J Clin Aesthet Dermatol (2012) 0.92
Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report. Dermatol Clin (2009) 0.91
Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier? J Clin Aesthet Dermatol (2013) 0.90
A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. J Drugs Dermatol (2009) 0.89
Psychosocial judgements and perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of adult and peer evaluations. Biopsychosoc Med (2011) 0.87
Skin cancer in asians: part 2: melanoma. J Clin Aesthet Dermatol (2009) 0.87
Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant. J Drugs Dermatol (2011) 0.86
Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. J Drugs Dermatol (2008) 0.85
Acute generalized exanthematous pustulosis: an enigmatic drug-induced reaction. Cutis (2009) 0.85
The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. Cutis (2007) 0.85
Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis. J Clin Aesthet Dermatol (2011) 0.85
Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin. J Clin Aesthet Dermatol (2013) 0.84
Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne. J Drugs Dermatol (2008) 0.84
Solitary sclerotic fibroma. J Clin Aesthet Dermatol (2009) 0.84
Healthcare utilization and costs of patients with rosacea in an insured population. J Drugs Dermatol (2008) 0.83
Comprehensive medical management of rosacea: an interim study report and literature review. J Clin Aesthet Dermatol (2008) 0.83
Skin cancer in asians: part 1: nonmelanoma skin cancer. J Clin Aesthet Dermatol (2009) 0.81
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options. Cutis (2006) 0.80
Absence of Degradation of Tretinoin When Benzoyl Peroxide is Combined with an Optimized Formulation of Tretinoin Gel (0.05%). J Clin Aesthet Dermatol (2010) 0.80
Tretinoin photostability: comparison of micronized tretinoin (0.05%) gel and tretinoin (0.025%) gel following exposure to ultraviolet a light. J Clin Aesthet Dermatol (2012) 0.80
Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses. J Clin Aesthet Dermatol (2009) 0.79
A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide. Cutis (2009) 0.79
Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria. J Clin Aesthet Dermatol (2013) 0.79
Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. J Clin Aesthet Dermatol (2011) 0.79
Tinea capitis in infants: recognition, evaluation, and management suggestions. J Clin Aesthet Dermatol (2012) 0.79
Systemic retinoid therapy: a status report on optimal use and safety of long-term therapy. Dermatol Clin (2007) 0.78
Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. J Clin Aesthet Dermatol (2011) 0.78
Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin. J Clin Aesthet Dermatol (2011) 0.78
Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris. Cutis (2007) 0.78
Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications. J Drugs Dermatol (2016) 0.77
Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. J Drugs Dermatol (2013) 0.77
Overcoming the Barrier Treatment of Ichthyosis: A Combination-therapy Approach. J Clin Aesthet Dermatol (2010) 0.77
Evolving perspectives on the etiology and pathogenesis of acne vulgaris. J Drugs Dermatol (2015) 0.77
Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream. J Drugs Dermatol (2014) 0.76
The sequence of inflammation, relevant biomarkers, and the pathogenesis of acne vulgaris: what does recent research show and what does it mean to the clinician? J Drugs Dermatol (2013) 0.76
Optimal management of papulopustular rosacea: rationale for combination therapy. J Drugs Dermatol (2012) 0.76
A status report on drug-associated acne and acneiform eruptions. J Drugs Dermatol (2010) 0.75
Efficacy and Tolerability of a Three-Step Acne System Containing a Solubilized Benzoyl Peroxide Lotion versus a Benzoyl Peroxide/Clindamycin Combination Product: An Investigator-Blind, Randomized, Parallel-Group Study. J Clin Aesthet Dermatol (2008) 0.75
Avoiding the legal "blemish": medicolegal pitfalls in dermatology. J Clin Aesthet Dermatol (2009) 0.75
Coal tar 2% foam in combination with a superpotent corticosteroid foam for plaque psoriasis: case report and clinical implications. J Clin Aesthet Dermatol (2010) 0.75
Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis. J Clin Aesthet Dermatol (2009) 0.75
Erythropoietic protoporphyria: a case report and literature review. J Clin Aesthet Dermatol (2010) 0.75
A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses. J Clin Aesthet Dermatol (2012) 0.75
Primary carcinosarcoma of the ear: case report and review of the literature. J Clin Aesthet Dermatol (2009) 0.75
Mycetoma clinically masquerading as squamous cell carcinoma: case report and literature review. J Clin Aesthet Dermatol (2009) 0.75
Atopic dermatitis and the stratum corneum: part 2: other structural and functional characteristics of the stratum corneum barrier in atopic skin. J Clin Aesthet Dermatol (2013) 0.75
Overstating Conclusions from Population-Based Data: Be Careful What You Wish For! J Drugs Dermatol (2016) 0.75
Topical retinoids in the management of acne: the best path to clear results. Cutis (2004) 0.75
The changing face of challenges in the management of acne and rosacea. J Drugs Dermatol (2014) 0.75
Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid. J Drugs Dermatol (2014) 0.75
Laser and light-based therapies for acne vulgaris: a current guide based on available data. J Drugs Dermatol (2010) 0.75
Topical tazarotene in acne vulgaris: treatment approaches. Cutis (2004) 0.75
Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction. J Drugs Dermatol (2008) 0.75
The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach. J Drugs Dermatol (2012) 0.75
Why are dermatologists still talking about acne? Because so many people have it... and we are always seeking better ways to manage it. J Drugs Dermatol (2011) 0.75
Spotlight on the Use of Nitric Oxide in Dermatology: What Is It? What Does It Do? Can It Become an Important Addition to the Therapeutic Armamentarium for Skin Disease? J Drugs Dermatol (2017) 0.75
Message from the guest editor. J Drugs Dermatol (2012) 0.75
What more can we learn about acne and rosacea? Just keep reading, questioning, and searching for clinical relevance beyond the limitations of clinical trials. J Drugs Dermatol (2013) 0.75
The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream. J Drugs Dermatol (2012) 0.75
Acne and rosacea. J Drugs Dermatol (2008) 0.75
The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris. J Drugs Dermatol (2017) 0.75
We are making progress with both acne and rosacea--but, let's face it! We still have a long way to go. J Drugs Dermatol (2010) 0.75
Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. J Drugs Dermatol (2013) 0.75
Comparative efficacy and safety results of topical hemostatic powder and sterile compressed foam sponge in second intention healing following Mohs micrographic surgery. J Drugs Dermatol (2010) 0.75
Hyperkeratotic papular eruptions on legs, arms, and back. Int J Dermatol (2010) 0.75
Management of Acne & Rosacea: Working Toward the Same Goals…Facing New Challenges. J Drugs Dermatol (2015) 0.75